SINGAPORE (March 16): Local medical robotics firm EndoMaster announced Thursday that it raised $20.5 million in March – one of the largest sums for Series B funding for medical technology companies in Singapore.

EndoMaster’s robotic-assisted surgical system is able to remove gastro-intestinal cancer tumours without the need for surgical incisions on the body or organ.

According to EndoMaster, gastro-intestinal cancer is diagnosed in over three million people worldwide and causes more than two million deaths every year.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook